Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Verve Therapeutics Inc (NASDAQ: VERV) was $6.91 for the day, up 4.07% from the previous closing price of $6.64. In other words, the price has increased by $4.07 from its previous closing price. On the day, 0.91 million shares were traded. VERV stock price reached its highest trading level at $7.03 during the session, while it also had its lowest trading level at $6.46.
Ratios:
Our analysis of VERV’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 17.24 and its Current Ratio is at 17.24. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on April 08, 2024, initiated with a Buy rating and assigned the stock a target price of $15.
On April 13, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $29.
On February 01, 2023, Cantor Fitzgerald started tracking the stock assigning a Neutral rating and target price of $21.Cantor Fitzgerald initiated its Neutral rating on February 01, 2023, with a $21 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 02 ’24 when Nickerson Joan sold 1,514 shares for $8.24 per share. The transaction valued at 12,475 led to the insider holds 8,659 shares of the business.
Dorval Allison sold 554 shares of VERV for $6,343 on Nov 29 ’23. The Chief Financial Officer now owns 4,060 shares after completing the transaction at $11.45 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERV now has a Market Capitalization of 577809344 and an Enterprise Value of 6189012. For the stock, the TTM Price-to-Sale (P/S) ratio is 46.15 while its Price-to-Book (P/B) ratio in mrq is 0.94. Its current Enterprise Value per Revenue stands at 0.526 whereas that against EBITDA is -0.028.
Stock Price History:
The Beta on a monthly basis for VERV is 1.95, which has changed by -0.5855181 over the last 52 weeks, in comparison to a change of 0.2006725 over the same period for the S&P500. Over the past 52 weeks, VERV has reached a high of $21.42, while it has fallen to a 52-week low of $6.42. The 50-Day Moving Average of the stock is -43.53%, while the 200-Day Moving Average is calculated to be -48.59%.
Shares Statistics:
VERV traded an average of 1.29M shares per day over the past three months and 1144980 shares per day over the past ten days. A total of 81.97M shares are outstanding, with a floating share count of 54.79M. Insiders hold about 30.25% of the company’s shares, while institutions hold 72.32% stake in the company. Shares short for VERV as of 1711584000 were 15357632 with a Short Ratio of 11.92, compared to 1709164800 on 12520660. Therefore, it implies a Short% of Shares Outstanding of 15357632 and a Short% of Float of 23.709999.
